Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2007-09-04
2007-09-04
Badio, Barbara P. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
active
11101357
ABSTRACT:
The invention relates to appetite-suppressing compositions obtained from botanical sources. More specifically, the invention relates to appetite-suppressing compositions comprising an extract product of anAsclepiasplant, methods of making an appetite-suppressing composition, and methods of suppressing an appetite.
REFERENCES:
patent: 6376657 (2002-04-01), Van Heerden et al.
patent: 2003/0152648 (2003-08-01), Corley et al.
patent: WO 03/041727 (2003-05-01), None
Warashina et al., “Steroidal glycosides from the aerial part ofAsclepias incarnata.” Phytochemistry, vol. 53, pp. 485-498, 2000.
Abe et al., “Pregnane Glycosides from the Roots ofAsclepias tuberosa,”Chem. Pharm. Bull.(Tokyo), 48(7):1017-1022 (2000).
Bent, “The Relative Safety of Ephedra Compared with Other Herbal Products,”Annals of Internal Medicine, 138(6):468-471 (2003).
Bonow et al., “Diet, Obesity and Cardiovascular Risk,”New England J. Med., 348(21):2057-2058 (2003).
Desai, “Cardiac Glycosides” (2000) Retrieved from the Internet: <URL: http://www.people.vcu.edu/˜urdesai/car.htm>.
El Sayed et al., “Pregnane Glycosides FromStapelia Variegata,”Phytochem., 39(2):395-403 (1995).
Grundy et al., “Definition of Metabolic Syndrome, Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition,”Circulation, 109(3):433-438 (2004).
Han et al., “Analysis of Obesity and Hyperinsulinemia in the Development of Metabolic Syndrome: San Antonio Heart Study,”Obesity Research, 10(9):923-931 (2002).
Marx, “Cellular Warriors at the Battle of the Bulge,”Science, 299(5608):846-849 (2003).
“Pleurisy Root-Asclepias tuberosa,” Physicians' Desk Reference for Herbal Medicines, 2nded., pp. 598-599 (2000).
U.S. Department of Agriculture,Natural Resources Conservation Service, Plant Guide, “Butterfly MilkweedAsclepias tuberosa L.” (Jan. 17, 2001).
U.S. Food and Drug Administration, U.S. Department of Health & Human Services, Press Release, “HHS Acts to Reduce Potential Risks of Dietary Supplements Containing Ephedra” (Feb. 28, 2003).
U.S. Food and Drug Administration, U.S. Department of Health & Human Services, Press Release, “FDA Issues Regulation Prohibiting Sale of Dietary Supplements Containing Ephedrine Alkaloids and Reiterates Its Advice That Consumers Stop Using These Products” (Feb. 6, 2004).
U.S. Food and Drug Administration, U.S. Department of Health & Human Services, Press Release, “HHS Unveils FDA Strategy To Help Reduce Obesity, New ‘Calories Count’ Approach Builds on HHS' Education, Research Efforts” (Mar. 12, 2004).
Warashina et al., “Steroidal glycosides from the aerial part ofAsclepias incarnata,”Phytochemistry, 53:485-498 (2000).
International Search Report for International (PCT) Patent Application No. PCT/US05/11632, dated Jun. 23, 2005.
Written Opinion of the International Searching Authority for International (PCT) Patent Application No. PCT/US05/11632, dated Jun. 23, 2005.
Dal Piaz et al., “Electrospray Ionization Mass Spectrometry for Identification and Structural Characterization of Pregnane Glycosides,”Rapid Comm. Mass. Spec., 19:1041-1052 (Mar. 29, 2005).
MacLean et al., “Increased ATP Content/Production in the Hypothalamus May be a Signal for Energy-Sensing of Satiety: Studies of the Anorectic Mechanism of a Plant Steroidal Glycoside,”Science Direct, Brain Research, 1020:1-11 (Jul. 20, 2004).
Nom et al., “Cardiac Glycosides: From Ancient History Through Withiring's Foxglove to Endogeneous Cardia Glycosides,”Dan. Medicinhist Arbog.: 119-132 (2004) (Abstract Only).
Schoner, “Ouabain, a New Steroid Hormone of Adrenal Gland and Hypothalamus,”Exp;. Clin. Endocrinol Diabetes, 108:449-454 (2000).
Warashina et al., “Steroidal Glycosides FromCynanchum Caudatum,”Phytochemistry, 39(1):199-204 (1995).
Warashina et al., “Steroidal Glycosides from Roots ofCynanchum Caudatum,”Phytochemistry, 44(5):917-923 (1997).
Warashina et al., “Steroidal Glycosides from the Aerial Part ofAsclepias incarnata,”Phytochemistry53:485-498 (2000).
Warashina et al., “Cardenolide and Oxypregnane Glycosides from the Root ofAsclepias incarnataL.,”Chem. Pharm. Bull.48(4):516-524 (2000).
Warashina et al., “Steroidal Glycosides from the Aerial Part ofAsclepias incarnateL. II.”,Chem. Pharm. Bull., 48(1):99-107 (Jan. 2000). (Abstract Only).
O'Neal, III Joseph M.
Raskin Ilya
Badio Barbara P.
Marshall & Gerstein & Borun LLP
Rutgers The State University of New Jersey
LandOfFree
Appetite-suppressing compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Appetite-suppressing compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Appetite-suppressing compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3747636